ArticleEClinicalMedicine2021

Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial.

Jean-Jacques Parienti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.